Skip to content

Vascular responses to COMBO stent for acute coronary syndrome by Optical Coherence Tomography Assessment

Vascular responses to COMBO stent for acute coronary syndrome by Optical Coherence Tomography Assessment - Vascular responses to COMBO stent for acute coronary syndrome by Optical Coherence Tomography Assessment

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000039919
Enrollment
30
Registered
2020-03-24
Start date
2020-03-12
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The patients with acute coronary syndrome

Interventions

All patients underwent percutaneous coronary intervention (PCI) for acute coronary syndrome (ACS) by using Combo stent.All patients were evaluated by Optical Coherence Tomography (OCT) immediately aft

Sponsors

ShonanKamakura general Hospital, Cardiology
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) The patients with ACS need for PCI. 2) Target lesions are thought native coronary arteries. 3) The patients are possible to take antiplatelet drugs. 4) The patients or legal representative people agree this study and write informed consents after they understand this study protocol.

Exclusion criteria

Exclusion criteria: 1) The patients with low ejection fraction (less than 20%). 2) The patients with recurrent myocardial infarction within 30 days. 3) The patients with fresh bleeding. 4) The patients with cerebral infarction within 6 months. 5) The patients with hemoglobin < 8.0 g/dl. 6) The patients with WBC <3000 or PLT < 100000. 7) The patients with positive HBV or HCV or HIV. 8) The patients with participate other clinical trial. 9, 10) The patients with pregnant women (including possible) or lactating women 11) The patients with renal failure (Cre>2.5 mg/dl) 12) The patients that research director judged inappropriate patients in this study.

Design outcomes

Primary

MeasureTime frame
The primary endpoint was that the degree of strut coverage which was evaluated by OCT at 1 month. Percentage of strut coverage was analyzed every 1 mm by OCT.

Countries

Japan

Contacts

Public ContactKoki Shishido

ShonanKamakura General Hospital Cardiology

koki10192002@yahoo.co.jp0467-46-1717

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026